Paper42004642
Management of Stage 1 Neurotrophic Keratopathy with Shelf-Stable, Cryopreserved Amniotic Membrane: A Retrospective Study.
Bauza AM. Clin Ophthalmol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Management of Stage 1 Neurotrophic Keratopathy with Shelf-Stable, Cryopreserved Amniotic Membrane: A Retrospective Study. Papers, record 42004642. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42004642
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Management of Stage 1 Neurotrophic Keratopathy with Shelf-Stable, Cryopreserved Amniotic Membrane: A Retrospective Study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38929602 | Sutureless Dehydrated Amniotic Membrane (Omnigen) Application Using a Specialised Bandage Contact Lens (OmniLenz) for the Treatment of Dry Eye Disease: A 6-Month Randomised Control Trial. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/38929602 | PubMed |
| 2 | 41394257 | Therapeutic Outcomes of Shelf-Stable, Cryopreserved Amniotic Membrane in Recalcitrant Keratopathy. | Clin Ophthalmol | 2025 | https://conductscience.org/library/papers/41394257 | PubMed |
| 3 | 37720008 | Association of Treatment Duration and Clinical Outcomes in Dry Eye Treatment with Sutureless Cryopreserved Amniotic Membrane. | Clin Ophthalmol | 2023 | https://conductscience.org/library/papers/37720008 | PubMed |
| 4 | 32309119 | Amniotic membrane transplantation for managing dry eye and neurotrophic keratitis. | Taiwan J Ophthalmol | 2020 | https://conductscience.org/library/papers/32309119 | PubMed |
| 5 | 32309118 | Basic science review of birth tissue uses in ophthalmology. | Taiwan J Ophthalmol | 2020 | https://conductscience.org/library/papers/32309118 | PubMed |
| 6 | 40270622 | The Prevalence of Corneal Sensitivity Loss in Patients with and without Dry Eye Disease. | Clin Ophthalmol | 2025 | https://conductscience.org/library/papers/40270622 | PubMed |
| 7 | 24480838 | Corneal sensitivity and morphology of the corneal subbasal nerve plexus in primary congenital glaucoma. | Eye (Lond) | 2014 | https://conductscience.org/library/papers/24480838 | PubMed |
| 8 | 25828513 | Etiologies, Quantitative Hypoesthesia, and Clinical Outcomes of Neurotrophic Keratopathy. | Eye Contact Lens | 2015 | https://conductscience.org/library/papers/25828513 | PubMed |
| 9 | 39659875 | The THINK Study: Testing Hypoesthesia and the Incidence of Neurotrophic Keratopathy in Cataract Patients with Dry Eye. | Clin Ophthalmol | 2024 | https://conductscience.org/library/papers/39659875 | PubMed |
| 10 | 40699103 | Evaluation of the relationship between dry eye syndrome severity and corneal sensitivity. | Arq Bras Oftalmol | 2025 | https://conductscience.org/library/papers/40699103 | PubMed |
| 11 | 35768054 | Neurotrophic Keratopathy in the United States: An Intelligent Research in Sight Registry Analysis. | Ophthalmology | 2022 | https://conductscience.org/library/papers/35768054 | PubMed |
| 12 | 23958840 | Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways. | Regul Pept | 2013 | https://conductscience.org/library/papers/23958840 | PubMed |
| 13 | 24672223 | Diagnosis and management of neurotrophic keratitis. | Clin Ophthalmol | 2014 | https://conductscience.org/library/papers/24672223 | PubMed |
| 14 | 36513157 | Comparison of Persistent Epithelial Defect Treatment With Sutureless Cryopreserved and Dehydrated Amniotic Membrane. | Am J Ophthalmol | 2023 | https://conductscience.org/library/papers/36513157 | PubMed |
| 15 | 26255576 | Corneal Sensitivity in Tear Dysfunction and its Correlation With Clinical Parameters and Blink Rate. | Am J Ophthalmol | 2015 | https://conductscience.org/library/papers/26255576 | PubMed |
| 16 | 34146016 | The relationship between corneal subbasal nerve density and corneal sensitivity in patients with Fuchs endothelial corneal dystrophy. | Indian J Ophthalmol | 2021 | https://conductscience.org/library/papers/34146016 | PubMed |
| 17 | 8951678 | CGRP increases the rate of corneal re-epithelialization in an in vitro whole mount preparation. | J Ocul Pharmacol Ther | 1996 | https://conductscience.org/library/papers/8951678 | PubMed |
| 19 | 38130153 | Neurotrophic keratopathy: Clinical presentation and outcomes in 354 eyes in a community-based population. | Eur J Ophthalmol | 2024 | https://conductscience.org/library/papers/38130153 | PubMed |
| 20 | 28834819 | Self-Retained Amniotic Membrane Combined With Antiviral Therapy for Herpetic Epithelial Keratitis. | Cornea | 2017 | https://conductscience.org/library/papers/28834819 | PubMed |
| 21 | 40099678 | Processing Methods Affect Biological Properties of Amniotic Membrane Sheet Products. | Cornea | 2025 | https://conductscience.org/library/papers/40099678 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42004642
GET https://conductscience.org/api/papers/v1/42004642/references?page=2